Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon F Roy

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
The British Journal of Dermatology|March 4, 2025
Congenital melanocytic nevi initiated by BRAF fusion oncogene with firmness, pruritus, and desmoplastic stromaSimon F Roy, Nnenna G Agim, Adnan Mir, et al.
Cancer Research|August 19, 2025
Cytotoxic CD8+ T Cells Downregulate GPX4 to Promote Ferroptosis in Melanoma that Drives Antitumor ImmunityKarine Flem-Karlsen, Ronan Talty, Meaghan K McGeary, et al.
Pathology|June 21, 2024
Tumour necrosis is a valuable histopathological prognostic parameter in melanomas of the vulva and vaginaSimon F Roy, Jumanah Baig, Ryan DeCoste, et al.
Journal of Cutaneous Medicine and Surgery|May 29, 2019
Incidence, Mortality, and Spatiotemporal Distribution of Cutaneous Malignant Melanoma Cases Across CanadaFeras M Ghazawi, Michelle Le, François Lagacé, et al.
Cancer Research|February 24, 2025
Tumorigenesis Driven by BRAFV600E Requires Secondary Mutations That Overcome Its Feedback Inhibition of RAC1 and MigrationSunyana Gadal, Jacob A Boyer, Simon F Roy, et al.
Biorxiv : the Preprint Server for Biology|April 25, 2024
Tumorigenesis driven by the BRAF<sup>V600E</sup> oncoprotein requires secondary mutations that overcome its feedback inhibition of migration and invasionSunyana Gadal, Jacob A Boyer, Simon F Roy, et al.
Molecular Cancer Therapeutics|December 21, 2025
Lipophilic Statins Deplete GPX4 to Promote Ferroptosis and Sensitize Cancer Cells to Immune Checkpoint BlockadeRonan Talty, Veronica T Brooks, Meaghan K McGeary, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
The British Journal of Dermatology|March 4, 2025
Congenital melanocytic nevi initiated by BRAF fusion oncogene with firmness, pruritus, and desmoplastic stromaSimon F Roy, Nnenna G Agim, Adnan Mir, et al.
Cancer Research|August 19, 2025
Cytotoxic CD8+ T Cells Downregulate GPX4 to Promote Ferroptosis in Melanoma that Drives Antitumor ImmunityKarine Flem-Karlsen, Ronan Talty, Meaghan K McGeary, et al.
Pathology|June 21, 2024
Tumour necrosis is a valuable histopathological prognostic parameter in melanomas of the vulva and vaginaSimon F Roy, Jumanah Baig, Ryan DeCoste, et al.
Journal of Cutaneous Medicine and Surgery|May 29, 2019
Incidence, Mortality, and Spatiotemporal Distribution of Cutaneous Malignant Melanoma Cases Across CanadaFeras M Ghazawi, Michelle Le, François Lagacé, et al.
Cancer Research|February 24, 2025
Tumorigenesis Driven by BRAFV600E Requires Secondary Mutations That Overcome Its Feedback Inhibition of RAC1 and MigrationSunyana Gadal, Jacob A Boyer, Simon F Roy, et al.
Biorxiv : the Preprint Server for Biology|April 25, 2024
Tumorigenesis driven by the BRAF<sup>V600E</sup> oncoprotein requires secondary mutations that overcome its feedback inhibition of migration and invasionSunyana Gadal, Jacob A Boyer, Simon F Roy, et al.
Molecular Cancer Therapeutics|December 21, 2025
Lipophilic Statins Deplete GPX4 to Promote Ferroptosis and Sensitize Cancer Cells to Immune Checkpoint BlockadeRonan Talty, Veronica T Brooks, Meaghan K McGeary, et al.
Pageof 7